“Novel In-Office Injectables for the Dermatology–Rheumatology Patient: Botulinum Toxin, Sodium Thiosulfate, and Hyaluronidase”, Can Dermatol Today, vol. 7, no. 3, pp. 4–10, Sep. 2026, doi: 10.58931/cdt.2026.73167.